Tagged Nemaura Medical

0

Glucose monitoring market could have new player – analyst says

UK-based medtech company Nemaura Medical is best placed to disrupt the global diabetic and pre-diabetic markets, according to GlobalData, after receiving European approval for its non-invasive continuous glucose monitor SugarBEAT. Nemaura Medical is set to launch SugarBEAT in the UK and German markets in Q3 2019. The company is on track to submit the US…

© 2019 Rapid Life Sciences Ltd, a Rapid News Group Company. All Rights Reserved.

Privacy policy

Terms and conditions